Skip to main navigation Skip to search Skip to main content

Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation

  • O. Shamriz
  • , A. J. Simon
  • , A. Lev
  • , O. Megged
  • , O. Ledder
  • , E. Picard
  • , L. Joseph
  • , V. Molho-Pessach
  • , Y. Tal
  • , P. Millman
  • , M. Slae
  • , R. Somech
  • , O. Toker
  • , M. Berger
  • Hebrew University of Jerusalem
  • Hadassah University Medical Centre
  • Sheba Medical Center at Tel Hashomer
  • Tel Aviv University
  • Shaare Zedek Medical Center

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology